BJCM
Blue Jay Capital Management Portfolio holdings
AUM
$147M
This Quarter Return
+8.28%
1 Year Return
+64.18%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$372M
AUM Growth
+$372M
(+30%)
Cap. Flow
+$76.3M
Cap. Flow
% of AUM
20.52%
Top 10 Holdings %
Top 10 Hldgs %
46.51%
Holding
36
New
15
Increased
5
Reduced
8
Closed
8
Top Buys
| 1 |
Cigna
CI
|
$20.1M |
| 2 |
AET
Aetna Inc
AET
|
$19.1M |
| 3 |
Humana
HUM
|
$19.1M |
| 4 |
HNT
HEALTH NET INC
HNT
|
$16.4M |
| 5 |
Perrigo
PRGO
|
$15.7M |
Top Sells
| 1 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$16.5M |
| 2 |
ENDP
Endo International plc
ENDP
|
$15.7M |
| 3 |
AKRX
Akorn, Inc.
AKRX
|
$14.3M |
| 4 |
Intuitive Surgical
ISRG
|
$13.9M |
| 5 |
United Therapeutics
UTHR
|
$12.9M |
Sector Composition
| 1 | Healthcare | 79.03% |
| 2 | Financials | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Cigna
CI
$80.3B
| $20.1M | 5.42% | +124,312 | New | +$20.1M |
|
|
AET
2
DELISTED
Aetna Inc
AET
| $19.1M | 5.15% | +150,187 | New | +$19.1M |
|
|
3
Humana
HUM
$36.5B
| $19.1M | 5.15% | +100,000 | New | +$19.1M |
|
4
Cooper Companies
COO
$13.4B
| $18M | 4.85% | 101,230 +41,230 | +69% | +$7.34M |
|
5
Centene
CNC
$14.3B
| $17M | 4.56% | 210,828 -39,172 | -16% | -$3.15M |
|
|
HNT
6
DELISTED
HEALTH NET INC
HNT
| $16.4M | 4.41% | +255,814 | New | +$16.4M |
|
7
Viatris
VTRS
$12.3B
| $16.3M | 4.38% | 240,000 -30,000 | -11% | -$2.04M |
|
|
SHPG
8
DELISTED
Shire pic
SHPG
| $15.9M | 4.27% | 65,638 -1,862 | -3% | -$450K |
|
|
9
Perrigo
PRGO
$3.27B
| $15.7M | 4.23% | +85,000 | New | +$15.7M |
|
|
RCPT
10
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $15.2M | 4.09% | 80,000 -30,000 | -27% | -$5.7M |
|
|
IPXL
11
DELISTED
Impax Laboratories, Inc.
IPXL
| $14.9M | 4.02% | 325,000 +40,000 | +14% | +$1.84M |
|
12
Vertex Pharmaceuticals
VRTX
$100B
| $14.2M | 3.82% | 115,000 +10,000 | +10% | +$1.23M |
|
13
BioMarin Pharmaceuticals
BMRN
$11.2B
| $12.9M | 3.48% | 94,665 +7,165 | +8% | +$980K |
|
|
ALXN
14
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $12.6M | 3.39% | +69,590 | New | +$12.6M |
|
15
Acadia Pharmaceuticals
ACAD
$4.38B
| $12.6M | 3.38% | +300,000 | New | +$12.6M |
|
|
CPHD
16
DELISTED
Cepheid Inc
CPHD
| $12.5M | 3.37% | 205,064 +5,064 | +3% | +$310K |
|
17
Alkermes
ALKS
$4.78B
| $12.1M | 3.25% | 187,500 -47,500 | -20% | -$3.06M |
|
18
Edwards Lifesciences
EW
$47.8B
| $11.7M | 3.14% | 81,828 -18,172 | -18% | -$2.59M |
|
19
Nektar Therapeutics
NKTR
$568M
| $11.6M | 3.11% | +925,000 | New | +$11.6M |
|
|
ALR
20
DELISTED
Alere Inc
ALR
| $11.3M | 3.05% | 215,000 -10,000 | -4% | -$527K |
|
21
Teva Pharmaceuticals
TEVA
$21.1B
| $10.3M | 2.78% | 175,000 -30,000 | -15% | -$1.77M |
|
|
SIRO
22
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
| $10M | 2.7% | +100,000 | New | +$10M |
|
|
THOR
23
DELISTED
THORATEC CORPORATION
THOR
| $9.58M | 2.58% | +215,000 | New | +$9.58M |
|
24
Smith & Nephew
SNN
$16.3B
| $9.34M | 2.51% | +275,000 | New | +$9.34M |
|
|
WMGI
25
DELISTED
Wright Medical Group Inc
WMGI
| $9.19M | 2.47% | +350,000 | New | +$9.19M |
|